Catalogo dei prodotti della ricerca

DI DONATO, VIOLANTE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.233
EU - Europa 3.751
AS - Asia 2.161
AF - Africa 170
SA - Sud America 66
OC - Oceania 29
Continente sconosciuto - Info sul continente non disponibili 1
Totale 14.411
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.090
IT - Italia 1.648
SG - Singapore 912
IN - India 462
SE - Svezia 441
DE - Germania 422
CN - Cina 353
FI - Finlandia 261
UA - Ucraina 162
GB - Regno Unito 133
RU - Federazione Russa 127
CA - Canada 99
TR - Turchia 93
TG - Togo 87
BG - Bulgaria 86
BE - Belgio 75
ID - Indonesia 70
IE - Irlanda 61
FR - Francia 50
MX - Messico 40
NL - Olanda 38
AT - Austria 36
IR - Iran 35
PH - Filippine 35
RO - Romania 32
PK - Pakistan 28
GR - Grecia 27
AU - Australia 26
AR - Argentina 25
EG - Egitto 24
IL - Israele 24
HK - Hong Kong 23
ES - Italia 22
PL - Polonia 22
IQ - Iraq 21
JP - Giappone 20
BR - Brasile 19
LT - Lituania 19
KR - Corea 16
PT - Portogallo 16
TW - Taiwan 16
ZA - Sudafrica 14
ET - Etiopia 13
CO - Colombia 12
CH - Svizzera 11
MY - Malesia 11
NO - Norvegia 11
HU - Ungheria 8
KE - Kenya 8
TH - Thailandia 8
YE - Yemen 7
DK - Danimarca 6
LV - Lettonia 6
NG - Nigeria 6
RS - Serbia 6
SK - Slovacchia (Repubblica Slovacca) 6
CZ - Repubblica Ceca 5
EC - Ecuador 5
MK - Macedonia 5
SI - Slovenia 5
MA - Marocco 4
SA - Arabia Saudita 4
BF - Burkina Faso 3
GH - Ghana 3
KZ - Kazakistan 3
NZ - Nuova Zelanda 3
PE - Perù 3
BD - Bangladesh 2
CL - Cile 2
CU - Cuba 2
EE - Estonia 2
JO - Giordania 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
MV - Maldive 2
PA - Panama 2
QA - Qatar 2
SC - Seychelles 2
TZ - Tanzania 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
CM - Camerun 1
DZ - Algeria 1
EU - Europa 1
LU - Lussemburgo 1
MN - Mongolia 1
MU - Mauritius 1
NP - Nepal 1
TN - Tunisia 1
UZ - Uzbekistan 1
VN - Vietnam 1
Totale 14.411
Salva come PNG Salva come JPEG
Città #
Fairfield 1.366
Ashburn 710
Singapore 681
Rome 668
Woodbridge 594
Chandler 555
Seattle 460
Houston 449
Wilmington 434
Cambridge 381
Ann Arbor 304
Santa Clara 253
Princeton 244
Beijing 211
San Paolo di Civitate 193
Plano 134
Millbury 132
Lawrence 126
Helsinki 121
San Diego 110
Boston 107
Dearborn 90
Bremen 89
Lomé 87
Sofia 86
Milan 77
Brussels 68
Jakarta 63
Andover 61
Dublin 58
Norwalk 49
Jacksonville 42
Stockholm 42
Toronto 42
Des Moines 39
New York 38
Los Angeles 37
Boardman 33
Vienna 32
Istanbul 29
Moscow 25
Federal 24
North York 22
Falkenstein 21
Florence 20
Frankfurt am Main 20
London 20
Antalya 17
Falls Church 17
Redwood City 17
Bologna 16
Hong Kong 16
Mannheim 16
Ottawa 16
Turin 16
Naples 15
Quezon City 14
San Mateo 14
Tokyo 14
Bühl 13
Melbourne 13
Karachi 12
Ankara 11
Nanjing 11
Sulaymaniyah 11
Tel Aviv 11
Vilnius 11
Bari 10
Hyderabad 10
Lappeenranta 10
Paris 10
Phoenix 10
Richardson 10
Auburn Hills 9
Cairo 9
Kunming 9
La Jolla 9
Mexico City 9
Oslo 9
Fremont 8
Hefei 8
Kaohsiung City 8
Mit Ghamr 8
Mumbai 8
Nairobi 8
Nuremberg 8
Angeles City 7
Brescia 7
Monterotondo 7
Palermo 7
Parma 7
Porto 7
Shanghai 7
Tehran 7
Addis Ababa 6
Barcelona 6
Bogotá 6
Brisbane 6
Chennai 6
Kemerovo 6
Totale 9.990
Salva come PNG Salva come JPEG
Nome #
Prevention, Screening, Treatment and Follow-Up of Gynecological Cancers. State of Art and Future Perspectives 576
Continuous versus cyclic oral contraceptives after laparoscopic excision of ovarian endometriomas: a systematic review and meta-analysis 150
HPV vaccination after primary treatment of HPV-related disease across different organ sites: a multidisciplinary comprehensive review and meta-analysis 149
A small molecule SMAC mimic LBW242 potentiates TRAIL- and anticancer drug-mediated cell death of ovarian cancer cells. 136
The impact of vaginal and endometrial microbiota in women's fertility: a review of literature 133
The Efficacy of Fractional {CO}2 Laser in the Treatment of Genitourinary Syndrome of Menopause. A Large Prospective Observational Study 130
NEOADJUVANT CHEMOTHERAPY FOLLOWED BY RADICAL SURGERY IN PATIENTS AFFECTED BY VAGINAL CARCINOMA 115
Quality of life and sexual function after type C2/type III radical hysterectomy for locally advanced cervical cancer: a prospective study. 114
Functions and the emerging role of the foetal liver into regenerative medicine 112
Brain metastases from malignant Brenner tumor of the ovary. a case report and a literature review 109
Recurrent Buschke-Löwenstein Tumor Treated Using CO2 Laser Vaporization 109
Bulky mesonephric adenocarcinoma of the uterine cervix treated with neoadjuvant chemotherapy and radical surgery: report of the first case 108
Type B versus Type C Radical Hysterectomy After Neoadjuvant Chemotherapy in Locally Advanced Cervical Carcinoma: A Propensity-Matched Analysis 107
Severe pelvic organ prolapse treated by vaginal native tissue repair: long-term analysis of outcomes in 146 patients 105
Autologous In Vitro Cultured Vaginal Tissue for Women Subjected to the Abbe-McIndoe Vaginoplasty: A Case Series 104
Laparoscopically guided minilaparotomy: a minimally invasive approach for the treatment of gynaecologic diseases in morbidly obese patients 103
Bevacizumab in ovarian cancer: state of the art and unanswered questions 101
Update on fertility-sparing treatment in primary and recurrent endometrial cancer 95
Does Hormone Replacement Therapy Impact the Prognosis in Endometrial Cancer Survivors? A Systematic Review 95
Fertility preservation in ovarian tumours 93
Comparison of anogenital distance and correlation with vulvo-vaginal atrophy: a pilot study on premenopausal and postmenopausal women 91
Laparotomic myomectomy in the 16th week of pregnancy: a case report. 90
Intraoperative aorta balloon occlusion: fertility preservation in patients with placenta previa accreta/increta 89
Impact of hormone receptor status and Ki-67 expression on disease-free survival in patients affected by high-risk endometrial cancer 89
Hormone replacement therapy after prophylactic risk-reducing salpingo-oophorectomy and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a meta-analysis 89
Pfizer-BioNtech COVID-19 vaccine in gynecologic oncology patients. A prospective cohort study 89
null 88
Feasibility and safety of type C2 total extraperitoneal abdominal radical hysterectomy (TEARH) for locally advanced cervical cancer 87
Ixabepilone for the treatment of endometrial cancer 87
PARP inhibition: a promising therapeutic target in ovarian cancer 87
Continent ileocolonic urinary diversion (rome pouch) for gynecologic malignancies: technique and feasibility. 84
Prognostic role of inguinal lymphadenectomy in vulvar squamous carcinoma. Younger and older patients should be equally treated. A prospective study and literature review 84
Chemotherapy in elderly patients with gynecological cancer 83
Vulvo-vaginal reconstruction after radical excision for treatment of vulvar cancer: evaluation of feasibility and morbidity of different surgical techniques 83
Assessing the long-term role of vaccination against hpv after loop electrosurgical excision procedure (leep):aA propensity-score matched comparison 83
Surgical treatment of an isolated omental cervical cancer recurrence: Report of a case and review of the literature 83
Age-Adjusted Charlson Comorbidity Index Predicts Survival in Endometrial Cancer Patients 82
Ospemifene for the treatment of vulvar and vaginal atrophy: A meta-analysis of randomized trials. Part I: Evaluation of efficacy 82
Splenic metastasis from cervical cancer: Case report and review of the literature 82
Continent urinary diversion 81
The age-adjusted Charlson comorbidity index as a predictor of survival in surgically treated vulvar cancer patients 81
Role of intraperitoneal chemotherapy in ovarian cancer in the platinum-taxane-based era: a meta-analysis 81
Dealing naturally with stumbling blocks on highways and byways of TRAIL induced signaling. 80
Adjuvant HPV Vaccination to Prevent Recurrent Cervical Dysplasia after Surgical Treatment: A Meta-Analysis 80
Immunotherapy in endometrial cancer: new scenarios on the horizon 79
Is postoperative computed tomography evaluation a prognostic indicator in patients with optimally debulked advanced ovarian cancer? 79
null 78
Efficacy and toxicity of bevacizumab in recurrent ovarian disease: an update meta-analysis on phase III trials 78
Trends in mortality after primary cytoreductive surgery for ovarian cancer: a systematic review and metaregression of randomized clinical trials and observational studies 78
CO2 laser therapy of the Bartholin's gland cyst: surgical data and functional short- and long-term results. 77
Management of endometriomas 77
The EOLO (End-of-Life Ovarian Cancer) Study: Approach to ovarian cancer patients at the end of life 77
Medical treatment of ovarian endometriomas: a prospective evaluation of the effect of dienogest on ovarian reserve, cyst diameter, and associated pain 76
Neoadjuvant chemotherapy followed by radical surgery in patients affected by vaginal carcinoma 75
Aortic lymphadenectomy in cervical cancer: Anatomy, classification and technique 74
Sexual health and quality of life assessment among ovarian cancer patients during chemotherapy 74
Retrospective analysis in 46 women with vulvovaginal atrophy treated with ospemifene for 12 weeks. improvement in overactive bladder symptoms 74
Miomectomia laparoscopica: fattibilità e learning curve. 73
Ospemifene for the treatment of vulvar and vaginal atrophy: a meta-analysis of randomized trials.part II: evaluation of tolerability and safety 72
Uterine asymptomatic myomas: An overview from diagnosis to treatment 72
Late morbidity following nerve-sparing radical hysterectomy. 72
Predictors and Patterns of Local, Regional, and Distant Failure in Squamous Cell Carcinoma of the Vulva 71
Therapeutic Approaches to Vulvar Cancer. A Review of Literature 70
Accuracy of pelvic ultrasound in preoperative evaluation of uterine myomas: a prospective cohort study 70
Intraperitoneal Chemotherapy: A Strategy for the Treatment of Refractory Ascites in Recurrent Endometrial Cancer Patients - Three Case Reports and Review of the Literature 70
Ovarian cancer: interplay of vitamin D signaling and miRNA action 70
Relationship between cervical excisional treatment for cervical intraepithelial neoplasia and obstetrical outcome 70
High-risk HPV-positive and -negative high-grade cervical dysplasia: Analysis of 5-year outcomes 70
EP06.09: Reliability of early fetal echocardiography (EFEC) for congenital heart disease (CHD) detection 69
null 69
Effect of neoadjuvant chemotherapy on primary treatment interval in patients with advanced ovarian cancer 69
Limits of ¹⁸F-fluorodeoxyglucose positron emission tomography in recurrence diagnosis of borderline ovarian tumor. 68
An Update of Laparoscopy in Cervical Cancer Staging: Is It a Useful Procedure? 68
CO2 Laser Treatment for Bartholin Gland Abscess: Ultrasound Evaluation of Risk Recurrence 67
Value of Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and Sentinel Lymph Node Biopsy in Endometrial Cancer Patients: A Prospective Study 67
Corrigendum to “Bartholin gland cancer” (Bartholin gland cancer (2017) 117 (1–11) 66
MODIFIED GLUTEAL FOLD ADVANCEMENT V-Y FLAP FOR VULVAR RECONSTRUCTION AFTER SURGERY FOR VULVAR MALIGNANCIES. 65
Recurrent mantle cell lymphoma in the uterine cervix: a case report 65
Complete remission after neoadjuvant chemotherapy of an advanced vulvar cancer patient: A case report 64
Tertiary cytoreductive surgery in recurrent epithelial ovarian cancer: a multicentre MITO retrospective study 64
The role of 2d/3d ultrasound to assess the response to neoadjuvant chemotherapy in locally advanced cervical cancer 63
Impact of covid-19 in gynecologic oncology: a nationwide italian survey of the SIGO and MITO groups 63
State of the art on HPV-related cervical lesions 62
An unusual case of secondary fibrosarcoma after treatment for breast cancer 62
Dose-Dense Neoadjuvant Chemotherapy plus Radical Surgery in Locally Advanced Cervical Cancer: A Phase II Study 62
Effects of neoadjuvant chemotherapy plus radical surgery as front line treatment strategy in patients affected by FIGO stage III cervical cancer 62
OP29.03: Identification of parametria by 2D-3D ultrasound in patients with cervical cancer: new perspectives and future applications 62
Oncological outcome of surgical management in patients with recurrent uterine cancer. a multicenter retrospective cohort study-ceegog ex01 trial 62
Hepatobiliary disease resection in patients with advanced epithelial ovarian cancer: prognostic role and optimal cytoreduction 62
Isolated contralateral groin relapse in vulvar cancer. 62
null 60
Urinary incontinence in women. state of art and medical treatment 60
null 60
Targeted drug delivery via folate receptors in recurrent ovarian cancer: a review. 60
Bmi is a key prognostic factor in stage iiic-iv ovarian cancer diagnosed prior 65 years old: a 10-year survival analysis 59
Morbidity associated with patent ductus arteriosus in preterm newborns: a retrospective case-control study 59
Surgical treatment of recurrent endometrial cancer: time for a paradigm shift 59
Advances in small molecule maintenance therapies for high-grade serous ovarian cancer 58
Feasibility and safety of type C2 extraperitoneal radical hysterectomy for locally advanced cervical cancer. 58
Implementation of laparoscopic approach for type B radical hysterectomy: A comparison with open surgical operations. 58
Totale 8.569
Salva come PNG Salva come JPEG
Categoria #
all - tutte 50.884
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.884
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.509 0 0 0 0 0 0 358 310 327 271 167 76
2020/20211.339 91 155 94 83 69 47 118 136 94 99 194 159
2021/20222.241 47 69 173 72 306 161 55 232 226 162 288 450
2022/20232.762 514 538 112 339 270 264 93 145 247 36 130 74
2023/20241.924 75 200 71 204 219 230 51 238 36 223 160 217
2024/20252.550 202 350 336 398 660 523 81 0 0 0 0 0
Totale 15.496